Regulation of TNF-alpha secretion by a specific melanocortin-1 receptor peptide agonist. 2003

Diane M Ignar, and John L Andrews, and Marilyn Jansen, and Michelle M Eilert, and Heather M Pink, and Peiyuan Lin, and Ronald G Sherrill, and Jerzy R Szewczyk, and James G Conway
Department of Metabolic Diseases, GlaxoSmithKline, Research Triangle Park, NC 27709, USA. diane.m.ignar@gsk.com

The lack of specific pharmacological tools has impeded the evaluation of the role of each melanocortin receptor (MCR) subtype in the myriad physiological effects of melanocortins. 154N-5 is an octapeptide (MFRdWFKPV-NH(2)) that was first identified as an MC1R antagonist in Xenopus melanophores [J. Biol. Chem. 269 (1994) 29846]. In this manuscript, we show that 154N-5 is a specific agonist for human and murine MC1R. The peptide has negligible activity at MC3R and MC4R and is 25-fold less potent and a weak agonist at MC5R. 154N-5 was tested in both a cellular and an animal model of tumor necrosis factor-alpha (TNF-alpha) secretion. The inhibitory efficacy of 154N-5 on TNF-alpha secretion in both models was similar to the nonselective agonist NDP-alpha-melanocyte stimulating hormone (NDP-alphaMSH), thus, we conclude that inhibition of TNF-alpha secretion by melanocortin peptides is mediated by MC1R. 154N-5 is a valuable new tool for the evaluation of specific contribution of MC1R agonism to physiological and pathological processes.

UI MeSH Term Description Entries
D008024 Ligands A molecule that binds to another molecule, used especially to refer to a small molecule that binds specifically to a larger molecule, e.g., an antigen binding to an antibody, a hormone or neurotransmitter binding to a receptor, or a substrate or allosteric effector binding to an enzyme. Ligands are also molecules that donate or accept a pair of electrons to form a coordinate covalent bond with the central metal atom of a coordination complex. (From Dorland, 27th ed) Ligand
D008070 Lipopolysaccharides Lipid-containing polysaccharides which are endotoxins and important group-specific antigens. They are often derived from the cell wall of gram-negative bacteria and induce immunoglobulin secretion. The lipopolysaccharide molecule consists of three parts: LIPID A, core polysaccharide, and O-specific chains (O ANTIGENS). When derived from Escherichia coli, lipopolysaccharides serve as polyclonal B-cell mitogens commonly used in laboratory immunology. (From Dorland, 28th ed) Lipopolysaccharide,Lipoglycans
D010446 Peptide Fragments Partial proteins formed by partial hydrolysis of complete proteins or generated through PROTEIN ENGINEERING techniques. Peptide Fragment,Fragment, Peptide,Fragments, Peptide
D002460 Cell Line Established cell cultures that have the potential to propagate indefinitely. Cell Lines,Line, Cell,Lines, Cell
D004305 Dose-Response Relationship, Drug The relationship between the dose of an administered drug and the response of the organism to the drug. Dose Response Relationship, Drug,Dose-Response Relationships, Drug,Drug Dose-Response Relationship,Drug Dose-Response Relationships,Relationship, Drug Dose-Response,Relationships, Drug Dose-Response
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D012333 RNA, Messenger RNA sequences that serve as templates for protein synthesis. Bacterial mRNAs are generally primary transcripts in that they do not require post-transcriptional processing. Eukaryotic mRNA is synthesized in the nucleus and must be exported to the cytoplasm for translation. Most eukaryotic mRNAs have a sequence of polyadenylic acid at the 3' end, referred to as the poly(A) tail. The function of this tail is not known for certain, but it may play a role in the export of mature mRNA from the nucleus as well as in helping stabilize some mRNA molecules by retarding their degradation in the cytoplasm. Messenger RNA,Messenger RNA, Polyadenylated,Poly(A) Tail,Poly(A)+ RNA,Poly(A)+ mRNA,RNA, Messenger, Polyadenylated,RNA, Polyadenylated,mRNA,mRNA, Non-Polyadenylated,mRNA, Polyadenylated,Non-Polyadenylated mRNA,Poly(A) RNA,Polyadenylated mRNA,Non Polyadenylated mRNA,Polyadenylated Messenger RNA,Polyadenylated RNA,RNA, Polyadenylated Messenger,mRNA, Non Polyadenylated
D014409 Tumor Necrosis Factor-alpha Serum glycoprotein produced by activated MACROPHAGES and other mammalian MONONUCLEAR LEUKOCYTES. It has necrotizing activity against tumor cell lines and increases ability to reject tumor transplants. Also known as TNF-alpha, it is only 30% homologous to TNF-beta (LYMPHOTOXIN), but they share TNF RECEPTORS. Cachectin,TNF-alpha,Tumor Necrosis Factor Ligand Superfamily Member 2,Cachectin-Tumor Necrosis Factor,TNF Superfamily, Member 2,TNFalpha,Tumor Necrosis Factor,Cachectin Tumor Necrosis Factor,Tumor Necrosis Factor alpha

Related Publications

Diane M Ignar, and John L Andrews, and Marilyn Jansen, and Michelle M Eilert, and Heather M Pink, and Peiyuan Lin, and Ronald G Sherrill, and Jerzy R Szewczyk, and James G Conway
June 2014, Endocrinology and metabolism (Seoul, Korea),
Diane M Ignar, and John L Andrews, and Marilyn Jansen, and Michelle M Eilert, and Heather M Pink, and Peiyuan Lin, and Ronald G Sherrill, and Jerzy R Szewczyk, and James G Conway
July 1998, Leukemia,
Diane M Ignar, and John L Andrews, and Marilyn Jansen, and Michelle M Eilert, and Heather M Pink, and Peiyuan Lin, and Ronald G Sherrill, and Jerzy R Szewczyk, and James G Conway
July 2018, Cell metabolism,
Diane M Ignar, and John L Andrews, and Marilyn Jansen, and Michelle M Eilert, and Heather M Pink, and Peiyuan Lin, and Ronald G Sherrill, and Jerzy R Szewczyk, and James G Conway
October 1997, The Journal of biological chemistry,
Diane M Ignar, and John L Andrews, and Marilyn Jansen, and Michelle M Eilert, and Heather M Pink, and Peiyuan Lin, and Ronald G Sherrill, and Jerzy R Szewczyk, and James G Conway
November 2003, FASEB journal : official publication of the Federation of American Societies for Experimental Biology,
Diane M Ignar, and John L Andrews, and Marilyn Jansen, and Michelle M Eilert, and Heather M Pink, and Peiyuan Lin, and Ronald G Sherrill, and Jerzy R Szewczyk, and James G Conway
March 2013, Biochimica et biophysica acta,
Diane M Ignar, and John L Andrews, and Marilyn Jansen, and Michelle M Eilert, and Heather M Pink, and Peiyuan Lin, and Ronald G Sherrill, and Jerzy R Szewczyk, and James G Conway
July 1996, Kidney international,
Diane M Ignar, and John L Andrews, and Marilyn Jansen, and Michelle M Eilert, and Heather M Pink, and Peiyuan Lin, and Ronald G Sherrill, and Jerzy R Szewczyk, and James G Conway
December 2005, Pigment cell research,
Diane M Ignar, and John L Andrews, and Marilyn Jansen, and Michelle M Eilert, and Heather M Pink, and Peiyuan Lin, and Ronald G Sherrill, and Jerzy R Szewczyk, and James G Conway
January 2016, Frontiers in genetics,
Diane M Ignar, and John L Andrews, and Marilyn Jansen, and Michelle M Eilert, and Heather M Pink, and Peiyuan Lin, and Ronald G Sherrill, and Jerzy R Szewczyk, and James G Conway
April 2003, Endocrinology,
Copied contents to your clipboard!